HMD HeraMED Limited
Healthcare · Medical Devices
· website
$0.04
52wk 0.01 – 0.06
Overall
—
Value
—
Growth
—
Health
—
Quality
—
Momentum
—
Dividend
—
Price
About HeraMED Limited
HeraMED Limited, a medical data and technology company, develops, manufactures, and sells home-based maternity monitoring technology in Australia and the United States. It provides HeraBEAT, a medical device for fetal and maternal heart rate used by pregnant women; and HeraCARE, a digital maternity and women's health platform that focuses on improving clinical outcomes while supporting more efficient and accessible models of care. The company has a collaboration agreement with Mayo Clinic. HeraMED Limited was founded in 2011 and is based in Hawthorn East, Australia.
Fundamental trends
Financial statements
Loading…
Key metrics
Market cap
$40.55M
P/E (trailing)
—
P/E (forward)
—
EPS (trailing)
0.00
Dividend yield
—
Payout ratio
0.0%
Beta
0.05
EV / EBITDA
-10.42
Price / Book
35.00
ROE
-223.2%
Operating margin
-751.5%
Net margin
0.0%
Total cash
$1.37M
Total debt
$0
Current ratio
4.49
Debt / Equity
—
Free cash flow
$-2.32M
Avg volume
812,477
Latest annual results
(FY ending 31 Dec 2025)
- Revenue$293.38K
- Gross profit$293.38K
- Operating income-$3.60M
- Net income-$4.13M
- Diluted EPS-0.00
- Free cash flow-$3.66M
- Net debt-$1.09M